References
- Johns D R, Heher K L, Miller N R, Smith K H. Leber's hereditary optic neuropathy. Clinical manifestations of the 14484 mutation. Arch Ophthalmol 1993; 111: 495–498
- Newman N J. Leber's hereditary optic neuropathy. New genetic considerations. Arch Neurol 1993; 50: 540–48
- Cullom M E, Heher K L, Miller N R, Savino P J, Johns D R. Leber's hereditary optic neuropathy masquerading as tobacco-alcohol amblyopia. Arch Ophthalmol 1993; 111: 1482–1485
- DeBois L G, Feldon S E. Evidence for a metabolic trigger for Leber's hereditary optic neuropathy. J Clin Neuro-ophthalmol 1992; 12: 15–16
- Shimizu H, Misumi C, Chihara E, Kashii S. Blunt head trauma led to detection of Leber's hereditary optic neuropathy. Rinsho Ganka 1993; 47: 617–620
- Harding A E, Sweeney M G, Miller D H, Mumford C J, Kellar-Wood H, Menard D, McDonald W I, Compston D AS. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992; 115: 979–989
- Flanigan K M, Johns D R. Association of the 11778 mitochondrial DNA mutation and demyelinating disease. Neurology 1993; 43: 2720–2722
- Kellar-Wood H, Robertson N, Govan G G, Compston D AS, Harding A E. Leber's hereditary optic neuropathy mitochondrial mutations in multiple sclerosis. Ann Neurol 1994; 36: 109–112
- Olsen N K, Hansen A W, Norby S, Edal A L, Jorgensen J R, Rosenberg T. Leber's hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harbouring the mitochondrial DNA 11778 mutation. Acta Neurol Scand 1995; 91: 326–329
- Nishimura M, Obayashi H, Ohta M, Uchiyama T, Hao Q, Saida T. No association of the 11778 mitochondrial DNA mutation and multiple sclerosis in Japan. Neurology 1995; 45: 1333–1334
- Beck R W, Cleary P A, Anderson M M, Jr, Keltner J L, Shults W T, Kaufman D I, Buckley E G, Corbett J J, Kupersmith M J, Miller N R, Savino P J, Guy J R, Trobe J D, McCrary J A, III, Smith C H, Chrousos G A, Thompson H S, Katz B J, Brodsky M C, Goodwin J A, Atwell C W, The Optic Neuritis Study Group. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992; 326: 581–588
- Beck R W, Cleary P A, The Optic Neuritis Study Group. Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol 1993; 111: 773–775
- Smith J L, Hoyt W F, Susac J O. Ocular fundus in acute Leber optic neuropathy. Arch Ophthalmol 1973; 90: 349–354
- Nikoskelainen E, Hoyt W F, Num-melin K. Ophthalmoscopic findings in Leber's hereditary optic neuropathy. II. The fundus findings in the affected family members. Arch Ophthalmol 1983; 101: 1059–1068
- Wakakura M, Yokoe J. Evidence for preserved direct pupillary light response in Leber's hereditary optic neuropathy. Br J Ophthalmol 1995; 79: 442–446
- Carroll W M, Mastaglia F L. Leber's optic neuropathy. A clinical and visual evoked potential study of affected and asymptomatic members of a six generation family. Brain 1979; 102: 559–580
- Keltner J L, Johnson C A, Spurr J O, Beck R W, The Optic Neuritis Study Group. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Arch Ophthalmol 1993; 111: 231–234
- Keltner J L, Johnson C A, Spurr J O, Beck R W, The Optic Neuritis Study Group. Casual field profile of optic neuritis. One-year follow-up in the optic neuritis treatment trial. Arch Ophthalmol 1994; 112: 946–953